biotech

Bio-Analyst

Research Platform
person
Tier-BPublic-ready6/11/2026

Thiamine

Nutrient status markers is closer to a research marker, so it should be read separately from a directly felt benefit.

Representative tier calculated from paper evidence that passed the collection audit.

Papers analyzed
20
Caution signal
Low
Representative score
53.6
Nutrient status markersCholesterol and triglyceridesSpecialized Treatment-Setting Signal

Main benefit evidence

The representative ingredient tier is calculated from these target-level evidence groups.

Nutrient status
3 studiesTier-B
Nutrient status markers
Fairly consistent positive signal in studiesResearch marker focusPatient-group study
This card is closer to a measured biomarker or lab outcome than a directly felt user benefit.
Closer to a research marker than a directly felt benefit.
Open metrics
>
Nutrient status and deficiency markers
No direct rate reported. Read direction and evidence strength together.
Evidence score
52.0
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Blood lipids
2 studiesTier-C
Cholesterol and triglycerides
Fairly consistent positive signal in studiesFelt benefit focusPatient-group study
Potential benefit studied in Blood lipids.
Open metrics
>
Cholesterol and triglycerides
No direct rate reported. Read direction and evidence strength together.
Evidence score
48.7
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Glucose and metabolic health
3 studiesTier-C
Glucose and metabolic health markers
Some positive signal observedResearch marker focusPatient-group study
This card is closer to a measured biomarker or lab outcome than a directly felt user benefit.
Closer to a research marker than a directly felt benefit.
Open metrics
>
Glucose and metabolic markers
No direct rate reported. Read direction and evidence strength together.
Evidence score
38.8
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Animal or cell research
3 studiesTier-C
Animal or Cell-Study Clue
Some positive signal observedResearch marker focusSupplement context
This is an early research clue, not direct human supplement-effect evidence.
Closer to a research marker than a directly felt benefit.
Animal or cell-study clue — not a human effect probability.
Open metrics
>
Animal, cell, or mechanism-only findings
No effect-rate metric is shown because this should be read as research context, not as a general supplement effect.
Evidence score
33.0
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Condition-specific evidence
1 studiesTier-C
Condition-specific health context in a specific context
Signal is still limitedResearch marker focusSupplement context
This result was studied for Condition-specific health context in a narrower population or condition-specific context. It should not be generalized as an everyday supplement effect.
Closer to a research marker than a directly felt benefit.
Open metrics
>
Condition-specific health context
No direct rate reported. Read direction and evidence strength together.
Evidence score
7.5
Score reflects signal strength. Tier also considers paper count, repetition, and study context.

Research clues (read separately)

Disease-specific, biomarker, animal, or cell-study findings — not everyday felt benefits.

Specialized clinical context
2 studiesTier-C
Specialized Treatment-Setting Signal
Some positive signal observedDisease markerSpecialized treatment
This evidence comes from contexts such as cancer, mortality, hospitalization, drug combination, or radiation studies. It should not be read as a general supplement effect.
Closer to a research marker than a directly felt benefit.
Open metrics
>
Nutrient status and deficiency markers
No direct rate reported. Read direction and evidence strength together.
Evidence score
39.1
Score reflects signal strength. Tier also considers paper count, repetition, and study context.

Recent research

Updated This Month10 new papers

10 new papers were added in this period. No new risk signal was identified.

What's new

10 new papers were added.No new risk signal was identified.

Most notable recent finding

This is the most meaningful new study in the latest update.
review
Why it mattersIt ranked highest among the newly collected papers for this ingredient in the latest update.
View paper

Study dosage range (reference only)

Lower dose
10
mg/kg/day
Higher dose
10
mg/kg/day
Dosages used in research papers, shown as reference context.
Not personal dosing instructions, recommendations, or safety limits.

Key cautions to review

Standalone side-effect signals and combination cautions are listed separately.

Caution index
0.0
Caution band: Low
Caution signals
0
Side effects + combos + curated rules
Key precautions
No combination caution signal is clear enough to show right now. This does not guarantee safety.
Standalone side effects, combination cautions, and positive combos are separated below.

Side-effect and combination signals

No standalone side-effect or combination signal is currently clear enough to show from the collected papers. This does not mean there is no concern.

Evidence summaries

Paper IDs and full lists are private. Only study types and summaries are shown.

Key Evidence #1
Public scholarly dataCitation signal: 107
review

A literature review of the current knowledge of the disease including related clinical phenotypes, treatment approaches, update of pathogenic variants, as well as in vitro and in vivo functional models that provide pathogenic evidence and propose mechanisms fo

Key Evidence #2
Public scholarly dataCitation signal: 102
observational

This study demonstrates that high blood levels ofThiamine can be achieved rapidly with oral thiamine hydrochloride, and is absorbed by both an active and nonsaturable passive process.

Key Evidence #3
Public scholarly dataCitation signal: 67
review

It could be concluded that although experimental studies mostly resulted in beneficial effects, clinical studies of appropriate size and duration focusing on the effect of thiamine supplementation/therapy on hard endpoints are missing at present.

3 more summariesLimited representative sample by study type.
>
Public scholarly dataCitation signal: 52
observational

There is not enough evidence to recommend this therapy in other types of pain due to the scarcity of high-quality studies, but combination therapy of diclofenac with TPC might have an analgesic superiority compared withdicl ofenac monotherapy in acute LBP.

Public scholarly dataCitation signal: 43
observational

Daily supplementation with an individualized ALA, carnosine, and thiamine supplement effectively reduced glucose concentration in type 2 diabetic patients, probably by increasing insulin production from the pancreas.

Public scholarly dataCitation signal: 39
observational

This real‐world study found that having a clinically unwell target population with high comorbidity and multiple presentations, coupled with challenges in cross‐cultural assessment is likely to complicate RCT findings and support a recommendation for patient‐s

Thiamine
arrow_backBack to list